Transforaminal 5% phenol neurolysis for the treatment of intractable cancer pain.
This is the first case report of using a transforaminal approach for phenol administration. A 76-yr-old patient with a history of leiomyosarcoma and multiple metastatic lesions had unremitting pain in the right thoracic and lumbar regions and had prohibitive opioid-induced side effects. The patient underwent phenol neurolysis using a transforaminal approach in 2 stages at 3 levels (L3-4, L1-2, and T12-L1). The patient had complete resolution of pain, without any complications, and opioid treatment was nearly discontinued. Transforaminal phenol neurolysis is a reasonable treatment option for patients suffering from intractable pain for whom conventional therapies have proven ineffective.
Candido
Kenneth D
KD
Department of Anesthesiology, Advocate Illinois Masonic Medical Center, 836 W. Wellington Ave., Chicago, IL 60657, USA. kdcandido@yahoo.com
Philip
Cyril N
CN
Ghaly
Ramsis F
RF
Knezevic
Nebojsa Nick
NN
D000368:Aged; D000701:Analgesics, Opioid / Q000009:adverse effects; D006801:Humans; D007890:Leiomyosarcoma / Q000150:complications* / Q000473:pathology; D008297:Male; D009362:Neoplasm Metastasis; D010148:Intractable Pain / Q000188:drug therapy* / Q000209:etiology*; D010166:Palliative Care; D010636:Phenols / Q000627:therapeutic use*; D013125:Spinal Neoplasms / Q000150:complications* / Q000473:pathology
D000701:Analgesics, Opioid; D010636:Phenols